Stay updated on Durvalumab ± Olaparib in Advanced Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab ± Olaparib in Advanced Bladder Cancer Clinical Trial page.

Latest updates to the Durvalumab ± Olaparib in Advanced Bladder Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedRevision: v3.6.3 is shown, replacing the previous v3.6.2. This reflects an update to the page's software build rather than changes to trial content.SummaryDifference0.1%

- Check25 days agoChange DetectedA new revision entry v3.6.2 was added to the record history. The previous revision v3.6.0 was removed from the history.SummaryDifference0.1%

- Check39 days agoChange DetectedAdds a note that the study is no longer looking for participants. Updates the record version to v3.6.0 and removes the previous v3.5.5 revision tag.SummaryDifference0.2%

- Check46 days agoChange DetectedThe page revision label was updated from v3.5.4 to v3.5.5, representing a minor update to the page history system.SummaryDifference0.1%

- Check68 days agoChange DetectedA new version entry (Version 41) was added to the study's record history with a submission date of 2026-05-07 and a Revision: v3.5.4. The prior Revision: v3.5.3 entry, dated 2026-01-30, was removed from the history.SummaryDifference0.3%

- Check82 days agoChange DetectedA new revision entry v3.5.3 was added to the study's record history, and the previous revision v3.5.2 was removed. This updates the visible version history to reflect the latest page revision.SummaryDifference0.1%

Stay in the know with updates to Durvalumab ± Olaparib in Advanced Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab ± Olaparib in Advanced Bladder Cancer Clinical Trial page.